nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomilnacipran—CYP2C8—Sulfadiazine—malaria	0.069	0.0863	CbGbCtD
Levomilnacipran—CYP2C8—Pyrimethamine—malaria	0.069	0.0863	CbGbCtD
Levomilnacipran—CYP2C19—Artemether—malaria	0.0492	0.0616	CbGbCtD
Levomilnacipran—CYP3A4—Clindamycin—malaria	0.0487	0.0609	CbGbCtD
Levomilnacipran—CYP2C19—Proguanil—malaria	0.0463	0.0579	CbGbCtD
Levomilnacipran—CYP2D6—Pyrimethamine—malaria	0.044	0.055	CbGbCtD
Levomilnacipran—CYP2D6—Artemether—malaria	0.0374	0.0468	CbGbCtD
Levomilnacipran—CYP2C8—Quinine—malaria	0.0355	0.0445	CbGbCtD
Levomilnacipran—CYP2D6—Proguanil—malaria	0.0352	0.044	CbGbCtD
Levomilnacipran—CYP2D6—Quinidine barbiturate—malaria	0.0333	0.0417	CbGbCtD
Levomilnacipran—CYP2C8—Quinidine—malaria	0.0312	0.0391	CbGbCtD
Levomilnacipran—CYP2C19—Quinine—malaria	0.0298	0.0373	CbGbCtD
Levomilnacipran—CYP3A4—Sulfadiazine—malaria	0.028	0.035	CbGbCtD
Levomilnacipran—CYP2C8—Dapsone—malaria	0.0269	0.0337	CbGbCtD
Levomilnacipran—ABCB1—Quinine—malaria	0.0241	0.0301	CbGbCtD
Levomilnacipran—CYP3A4—Artemether—malaria	0.0238	0.0298	CbGbCtD
Levomilnacipran—CYP2D6—Quinine—malaria	0.0227	0.0284	CbGbCtD
Levomilnacipran—CYP2C19—Dapsone—malaria	0.0226	0.0283	CbGbCtD
Levomilnacipran—CYP3A4—Proguanil—malaria	0.0224	0.028	CbGbCtD
Levomilnacipran—CYP3A4—Doxycycline—malaria	0.0212	0.0265	CbGbCtD
Levomilnacipran—ABCB1—Quinidine—malaria	0.0211	0.0264	CbGbCtD
Levomilnacipran—CYP2D6—Quinidine—malaria	0.0199	0.0249	CbGbCtD
Levomilnacipran—CYP3A4—Quinine—malaria	0.0144	0.018	CbGbCtD
Levomilnacipran—CYP3A4—Quinidine—malaria	0.0127	0.0158	CbGbCtD
Levomilnacipran—CYP3A4—Dapsone—malaria	0.0109	0.0137	CbGbCtD
Levomilnacipran—SLC6A4—blood plasma—malaria	0.00275	0.0817	CbGeAlD
Levomilnacipran—CYP2C19—blood plasma—malaria	0.00228	0.0677	CbGeAlD
Levomilnacipran—CYP2C8—blood plasma—malaria	0.00199	0.0591	CbGeAlD
Levomilnacipran—SLC6A4—hematopoietic system—malaria	0.00152	0.0452	CbGeAlD
Levomilnacipran—CYP2J2—liver—malaria	0.00146	0.0434	CbGeAlD
Levomilnacipran—CYP3A4—blood plasma—malaria	0.00135	0.04	CbGeAlD
Levomilnacipran—CYP2D6—blood plasma—malaria	0.00133	0.0394	CbGeAlD
Levomilnacipran—CYP2C19—hematopoietic system—malaria	0.00126	0.0374	CbGeAlD
Levomilnacipran—CYP2J2—brain—malaria	0.00116	0.0344	CbGeAlD
Levomilnacipran—CYP2C8—hematopoietic system—malaria	0.0011	0.0327	CbGeAlD
Levomilnacipran—SLC6A4—digestive system—malaria	0.00106	0.0314	CbGeAlD
Levomilnacipran—SLC6A4—blood—malaria	0.00101	0.0299	CbGeAlD
Levomilnacipran—ABCB1—blood plasma—malaria	0.000954	0.0283	CbGeAlD
Levomilnacipran—CYP2C8—kidney—malaria	0.000901	0.0268	CbGeAlD
Levomilnacipran—CYP2C19—digestive system—malaria	0.000876	0.026	CbGeAlD
Levomilnacipran—CYP2C19—blood—malaria	0.000835	0.0248	CbGeAlD
Levomilnacipran—CYP3A4—hematopoietic system—malaria	0.000745	0.0221	CbGeAlD
Levomilnacipran—CYP2D6—hematopoietic system—malaria	0.000733	0.0218	CbGeAlD
Levomilnacipran—CYP2C8—blood—malaria	0.000729	0.0216	CbGeAlD
Levomilnacipran—Neutropenia—Quinidine barbiturate—malaria	0.000653	0.00391	CcSEcCtD
Levomilnacipran—CYP2C19—liver—malaria	0.000653	0.0194	CbGeAlD
Levomilnacipran—Convulsion—Sulfadiazine—malaria	0.000639	0.00383	CcSEcCtD
Levomilnacipran—SLC6A4—brain—malaria	0.000625	0.0186	CbGeAlD
Levomilnacipran—Diarrhoea—Proguanil—malaria	0.000621	0.00372	CcSEcCtD
Levomilnacipran—Hepatitis—Quinine—malaria	0.000619	0.00371	CcSEcCtD
Levomilnacipran—Hepatitis—Quinidine—malaria	0.000619	0.00371	CcSEcCtD
Levomilnacipran—Stevens-Johnson syndrome—Quinidine barbiturate—malaria	0.000617	0.0037	CcSEcCtD
Levomilnacipran—Urinary tract disorder—Quinine—malaria	0.000612	0.00366	CcSEcCtD
Levomilnacipran—Urinary tract disorder—Quinidine—malaria	0.000612	0.00366	CcSEcCtD
Levomilnacipran—CYP3A4—kidney—malaria	0.000611	0.0181	CbGeAlD
Levomilnacipran—Urethral disorder—Quinine—malaria	0.000607	0.00364	CcSEcCtD
Levomilnacipran—Urethral disorder—Quinidine—malaria	0.000607	0.00364	CcSEcCtD
Levomilnacipran—CYP2D6—kidney—malaria	0.000601	0.0178	CbGeAlD
Levomilnacipran—Erythema multiforme—Clindamycin—malaria	0.000597	0.00358	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Sulfadiazine—malaria	0.00059	0.00353	CcSEcCtD
Levomilnacipran—Hepatobiliary disease—Pentoxifylline—malaria	0.000588	0.00352	CcSEcCtD
Levomilnacipran—Flushing—Clindamycin—malaria	0.000586	0.00351	CcSEcCtD
Levomilnacipran—Erythema multiforme—Quinine—malaria	0.000586	0.00351	CcSEcCtD
Levomilnacipran—Erythema multiforme—Quinidine—malaria	0.000586	0.00351	CcSEcCtD
Levomilnacipran—Eye disorder—Quinidine—malaria	0.000579	0.00347	CcSEcCtD
Levomilnacipran—Eye disorder—Quinine—malaria	0.000579	0.00347	CcSEcCtD
Levomilnacipran—Vomiting—Proguanil—malaria	0.000577	0.00346	CcSEcCtD
Levomilnacipran—Flushing—Quinidine—malaria	0.000575	0.00344	CcSEcCtD
Levomilnacipran—Flushing—Quinine—malaria	0.000575	0.00344	CcSEcCtD
Levomilnacipran—Cardiac disorder—Quinine—malaria	0.000575	0.00344	CcSEcCtD
Levomilnacipran—Cardiac disorder—Quinidine—malaria	0.000575	0.00344	CcSEcCtD
Levomilnacipran—Anorexia—Sulfadiazine—malaria	0.000574	0.00344	CcSEcCtD
Levomilnacipran—Rash—Proguanil—malaria	0.000572	0.00343	CcSEcCtD
Levomilnacipran—Dermatitis—Proguanil—malaria	0.000572	0.00342	CcSEcCtD
Levomilnacipran—CYP2C8—liver—malaria	0.00057	0.0169	CbGeAlD
Levomilnacipran—Headache—Proguanil—malaria	0.000568	0.0034	CcSEcCtD
Levomilnacipran—Hepatitis—Quinidine barbiturate—malaria	0.000559	0.00335	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Quinidine—malaria	0.000558	0.00334	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Quinine—malaria	0.000558	0.00334	CcSEcCtD
Levomilnacipran—Hepatitis—Pentoxifylline—malaria	0.000558	0.00334	CcSEcCtD
Levomilnacipran—Hallucination—Quinidine barbiturate—malaria	0.000556	0.00333	CcSEcCtD
Levomilnacipran—Chills—Quinine—malaria	0.000556	0.00333	CcSEcCtD
Levomilnacipran—Chills—Quinidine—malaria	0.000556	0.00333	CcSEcCtD
Levomilnacipran—Urinary tract disorder—Quinidine barbiturate—malaria	0.000552	0.00331	CcSEcCtD
Levomilnacipran—SLC6A2—brain—malaria	0.00055	0.0163	CbGeAlD
Levomilnacipran—Urethral disorder—Quinidine barbiturate—malaria	0.000548	0.00328	CcSEcCtD
Levomilnacipran—Insomnia—Sulfadiazine—malaria	0.000545	0.00326	CcSEcCtD
Levomilnacipran—Mental disorder—Quinine—malaria	0.000543	0.00325	CcSEcCtD
Levomilnacipran—Mental disorder—Quinidine—malaria	0.000543	0.00325	CcSEcCtD
Levomilnacipran—Flatulence—Clindamycin—malaria	0.000542	0.00324	CcSEcCtD
Levomilnacipran—Malnutrition—Quinidine—malaria	0.000539	0.00323	CcSEcCtD
Levomilnacipran—Malnutrition—Quinine—malaria	0.000539	0.00323	CcSEcCtD
Levomilnacipran—Nausea—Proguanil—malaria	0.000539	0.00323	CcSEcCtD
Levomilnacipran—Dysgeusia—Clindamycin—malaria	0.000538	0.00322	CcSEcCtD
Levomilnacipran—Vision blurred—Dapsone—malaria	0.000535	0.00321	CcSEcCtD
Levomilnacipran—Erythema multiforme—Quinidine barbiturate—malaria	0.000529	0.00317	CcSEcCtD
Levomilnacipran—ABCB1—hematopoietic system—malaria	0.000527	0.0157	CbGeAlD
Levomilnacipran—Decreased appetite—Sulfadiazine—malaria	0.000524	0.00314	CcSEcCtD
Levomilnacipran—Eye disorder—Quinidine barbiturate—malaria	0.000522	0.00313	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Sulfadiazine—malaria	0.00052	0.00311	CcSEcCtD
Levomilnacipran—Flushing—Quinidine barbiturate—malaria	0.000519	0.00311	CcSEcCtD
Levomilnacipran—Cardiac disorder—Quinidine barbiturate—malaria	0.000519	0.00311	CcSEcCtD
Levomilnacipran—CYP3A4—digestive system—malaria	0.000518	0.0154	CbGeAlD
Levomilnacipran—Flushing—Pentoxifylline—malaria	0.000518	0.0031	CcSEcCtD
Levomilnacipran—CYP2D6—digestive system—malaria	0.00051	0.0151	CbGeAlD
Levomilnacipran—Vision blurred—Quinidine—malaria	0.000508	0.00304	CcSEcCtD
Levomilnacipran—Vision blurred—Quinine—malaria	0.000508	0.00304	CcSEcCtD
Levomilnacipran—Tremor—Quinidine—malaria	0.000505	0.00303	CcSEcCtD
Levomilnacipran—Tremor—Quinine—malaria	0.000505	0.00303	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Quinidine barbiturate—malaria	0.000504	0.00302	CcSEcCtD
Levomilnacipran—Chills—Quinidine barbiturate—malaria	0.000502	0.003	CcSEcCtD
Levomilnacipran—Agitation—Quinidine—malaria	0.000495	0.00297	CcSEcCtD
Levomilnacipran—Agitation—Quinine—malaria	0.000495	0.00297	CcSEcCtD
Levomilnacipran—CYP3A4—blood—malaria	0.000493	0.0147	CbGeAlD
Levomilnacipran—Gastrointestinal pain—Sulfadiazine—malaria	0.000493	0.00295	CcSEcCtD
Levomilnacipran—Leukopenia—Clindamycin—malaria	0.000492	0.00295	CcSEcCtD
Levomilnacipran—Mental disorder—Quinidine barbiturate—malaria	0.00049	0.00293	CcSEcCtD
Levomilnacipran—Malnutrition—Quinidine barbiturate—malaria	0.000487	0.00291	CcSEcCtD
Levomilnacipran—CYP2D6—blood—malaria	0.000486	0.0144	CbGeAlD
Levomilnacipran—Syncope—Quinidine—malaria	0.000484	0.0029	CcSEcCtD
Levomilnacipran—Syncope—Quinine—malaria	0.000484	0.0029	CcSEcCtD
Levomilnacipran—Leukopenia—Quinine—malaria	0.000483	0.00289	CcSEcCtD
Levomilnacipran—Leukopenia—Quinidine—malaria	0.000483	0.00289	CcSEcCtD
Levomilnacipran—Flatulence—Pentoxifylline—malaria	0.000479	0.00287	CcSEcCtD
Levomilnacipran—Urticaria—Sulfadiazine—malaria	0.000479	0.00287	CcSEcCtD
Levomilnacipran—Tension—Quinidine barbiturate—malaria	0.000477	0.00286	CcSEcCtD
Levomilnacipran—Tension—Pentoxifylline—malaria	0.000477	0.00285	CcSEcCtD
Levomilnacipran—Palpitations—Quinidine—malaria	0.000476	0.00285	CcSEcCtD
Levomilnacipran—Palpitations—Quinine—malaria	0.000476	0.00285	CcSEcCtD
Levomilnacipran—Abdominal pain—Sulfadiazine—malaria	0.000476	0.00285	CcSEcCtD
Levomilnacipran—Body temperature increased—Sulfadiazine—malaria	0.000476	0.00285	CcSEcCtD
Levomilnacipran—Dysgeusia—Pentoxifylline—malaria	0.000476	0.00285	CcSEcCtD
Levomilnacipran—Hypertension—Clindamycin—malaria	0.000475	0.00284	CcSEcCtD
Levomilnacipran—Loss of consciousness—Quinine—malaria	0.000474	0.00284	CcSEcCtD
Levomilnacipran—Loss of consciousness—Quinidine—malaria	0.000474	0.00284	CcSEcCtD
Levomilnacipran—Convulsion—Quinine—malaria	0.000467	0.0028	CcSEcCtD
Levomilnacipran—Convulsion—Quinidine—malaria	0.000467	0.0028	CcSEcCtD
Levomilnacipran—Chest pain—Quinidine—malaria	0.000459	0.00275	CcSEcCtD
Levomilnacipran—Chest pain—Quinine—malaria	0.000459	0.00275	CcSEcCtD
Levomilnacipran—Vision blurred—Quinidine barbiturate—malaria	0.000459	0.00275	CcSEcCtD
Levomilnacipran—Vision blurred—Pentoxifylline—malaria	0.000458	0.00274	CcSEcCtD
Levomilnacipran—Tremor—Quinidine barbiturate—malaria	0.000456	0.00273	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000456	0.00273	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000456	0.00273	CcSEcCtD
Levomilnacipran—Tremor—Pentoxifylline—malaria	0.000455	0.00273	CcSEcCtD
Levomilnacipran—Tachycardia—Dapsone—malaria	0.000453	0.00271	CcSEcCtD
Levomilnacipran—CYP2C8—brain—malaria	0.000452	0.0134	CbGeAlD
Levomilnacipran—Agitation—Quinidine barbiturate—malaria	0.000447	0.00268	CcSEcCtD
Levomilnacipran—Agitation—Pentoxifylline—malaria	0.000446	0.00267	CcSEcCtD
Levomilnacipran—Hypersensitivity—Sulfadiazine—malaria	0.000444	0.00266	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Clindamycin—malaria	0.000439	0.00263	CcSEcCtD
Levomilnacipran—Syncope—Quinidine barbiturate—malaria	0.000436	0.00261	CcSEcCtD
Levomilnacipran—Leukopenia—Quinidine barbiturate—malaria	0.000436	0.00261	CcSEcCtD
Levomilnacipran—Leukopenia—Pentoxifylline—malaria	0.000435	0.0026	CcSEcCtD
Levomilnacipran—Shock—Quinidine—malaria	0.000433	0.00259	CcSEcCtD
Levomilnacipran—Shock—Quinine—malaria	0.000433	0.00259	CcSEcCtD
Levomilnacipran—ABCB1—kidney—malaria	0.000432	0.0128	CbGeAlD
Levomilnacipran—Nervous system disorder—Quinine—malaria	0.000432	0.00258	CcSEcCtD
Levomilnacipran—Nervous system disorder—Quinidine—malaria	0.000432	0.00258	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Quinidine—malaria	0.000431	0.00258	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Quinine—malaria	0.000431	0.00258	CcSEcCtD
Levomilnacipran—Palpitations—Quinidine barbiturate—malaria	0.00043	0.00258	CcSEcCtD
Levomilnacipran—Tachycardia—Quinidine—malaria	0.000429	0.00257	CcSEcCtD
Levomilnacipran—Tachycardia—Quinine—malaria	0.000429	0.00257	CcSEcCtD
Levomilnacipran—Palpitations—Pentoxifylline—malaria	0.000429	0.00257	CcSEcCtD
Levomilnacipran—Loss of consciousness—Quinidine barbiturate—malaria	0.000428	0.00256	CcSEcCtD
Levomilnacipran—Skin disorder—Quinidine—malaria	0.000427	0.00256	CcSEcCtD
Levomilnacipran—Skin disorder—Quinine—malaria	0.000427	0.00256	CcSEcCtD
Levomilnacipran—Pruritus—Sulfadiazine—malaria	0.000426	0.00255	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Quinidine—malaria	0.000425	0.00255	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Quinine—malaria	0.000425	0.00255	CcSEcCtD
Levomilnacipran—Convulsion—Quinidine barbiturate—malaria	0.000422	0.00253	CcSEcCtD
Levomilnacipran—Convulsion—Pentoxifylline—malaria	0.000421	0.00252	CcSEcCtD
Levomilnacipran—Anorexia—Quinine—malaria	0.000419	0.00251	CcSEcCtD
Levomilnacipran—Anorexia—Quinidine—malaria	0.000419	0.00251	CcSEcCtD
Levomilnacipran—Insomnia—Dapsone—malaria	0.000419	0.00251	CcSEcCtD
Levomilnacipran—Hypertension—Pentoxifylline—malaria	0.000419	0.00251	CcSEcCtD
Levomilnacipran—Hypotension—Clindamycin—malaria	0.000419	0.00251	CcSEcCtD
Levomilnacipran—Chest pain—Quinidine barbiturate—malaria	0.000414	0.00248	CcSEcCtD
Levomilnacipran—Chest pain—Pentoxifylline—malaria	0.000414	0.00248	CcSEcCtD
Levomilnacipran—Anxiety—Quinidine barbiturate—malaria	0.000413	0.00247	CcSEcCtD
Levomilnacipran—Diarrhoea—Sulfadiazine—malaria	0.000412	0.00247	CcSEcCtD
Levomilnacipran—Anxiety—Pentoxifylline—malaria	0.000412	0.00247	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000411	0.00246	CcSEcCtD
Levomilnacipran—Hypotension—Quinidine—malaria	0.000411	0.00246	CcSEcCtD
Levomilnacipran—Hypotension—Quinine—malaria	0.000411	0.00246	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000411	0.00246	CcSEcCtD
Levomilnacipran—Dry mouth—Pentoxifylline—malaria	0.000404	0.00242	CcSEcCtD
Levomilnacipran—Dyspnoea—Clindamycin—malaria	0.0004	0.0024	CcSEcCtD
Levomilnacipran—Dyspepsia—Clindamycin—malaria	0.000395	0.00236	CcSEcCtD
Levomilnacipran—Infection—Pentoxifylline—malaria	0.000394	0.00236	CcSEcCtD
Levomilnacipran—Dyspnoea—Quinidine—malaria	0.000392	0.00235	CcSEcCtD
Levomilnacipran—Dyspnoea—Quinine—malaria	0.000392	0.00235	CcSEcCtD
Levomilnacipran—Shock—Quinidine barbiturate—malaria	0.000391	0.00234	CcSEcCtD
Levomilnacipran—Shock—Pentoxifylline—malaria	0.00039	0.00234	CcSEcCtD
Levomilnacipran—Nervous system disorder—Quinidine barbiturate—malaria	0.000389	0.00233	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Quinidine barbiturate—malaria	0.000389	0.00233	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Pentoxifylline—malaria	0.000388	0.00232	CcSEcCtD
Levomilnacipran—Tachycardia—Quinidine barbiturate—malaria	0.000388	0.00232	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Clindamycin—malaria	0.000387	0.00232	CcSEcCtD
Levomilnacipran—Tachycardia—Pentoxifylline—malaria	0.000387	0.00232	CcSEcCtD
Levomilnacipran—Fatigue—Clindamycin—malaria	0.000387	0.00232	CcSEcCtD
Levomilnacipran—CYP3A4—liver—malaria	0.000386	0.0115	CbGeAlD
Levomilnacipran—Skin disorder—Quinidine barbiturate—malaria	0.000386	0.00231	CcSEcCtD
Levomilnacipran—Skin disorder—Pentoxifylline—malaria	0.000385	0.00231	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Quinidine barbiturate—malaria	0.000384	0.0023	CcSEcCtD
Levomilnacipran—Constipation—Clindamycin—malaria	0.000384	0.0023	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Pentoxifylline—malaria	0.000383	0.0023	CcSEcCtD
Levomilnacipran—Vomiting—Sulfadiazine—malaria	0.000383	0.00229	CcSEcCtD
Levomilnacipran—Decreased appetite—Quinidine—malaria	0.000383	0.00229	CcSEcCtD
Levomilnacipran—Decreased appetite—Quinine—malaria	0.000383	0.00229	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Quinidine—malaria	0.00038	0.00228	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Quinine—malaria	0.00038	0.00228	CcSEcCtD
Levomilnacipran—Rash—Sulfadiazine—malaria	0.00038	0.00227	CcSEcCtD
Levomilnacipran—CYP2D6—liver—malaria	0.00038	0.0113	CbGeAlD
Levomilnacipran—Dermatitis—Sulfadiazine—malaria	0.000379	0.00227	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Dapsone—malaria	0.000379	0.00227	CcSEcCtD
Levomilnacipran—Anorexia—Quinidine barbiturate—malaria	0.000379	0.00227	CcSEcCtD
Levomilnacipran—Anorexia—Pentoxifylline—malaria	0.000378	0.00226	CcSEcCtD
Levomilnacipran—Headache—Sulfadiazine—malaria	0.000377	0.00226	CcSEcCtD
Levomilnacipran—Hypotension—Quinidine barbiturate—malaria	0.000371	0.00222	CcSEcCtD
Levomilnacipran—Hypotension—Pentoxifylline—malaria	0.00037	0.00222	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Clindamycin—malaria	0.000367	0.0022	CcSEcCtD
Levomilnacipran—ABCB1—digestive system—malaria	0.000367	0.0109	CbGeAlD
Levomilnacipran—Abdominal pain—Dapsone—malaria	0.000367	0.0022	CcSEcCtD
Levomilnacipran—Body temperature increased—Dapsone—malaria	0.000367	0.0022	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Quinidine—malaria	0.00036	0.00216	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Quinine—malaria	0.00036	0.00216	CcSEcCtD
Levomilnacipran—Insomnia—Pentoxifylline—malaria	0.000359	0.00215	CcSEcCtD
Levomilnacipran—Nausea—Sulfadiazine—malaria	0.000358	0.00214	CcSEcCtD
Levomilnacipran—Urticaria—Clindamycin—malaria	0.000356	0.00213	CcSEcCtD
Levomilnacipran—Abdominal pain—Clindamycin—malaria	0.000355	0.00212	CcSEcCtD
Levomilnacipran—Body temperature increased—Clindamycin—malaria	0.000355	0.00212	CcSEcCtD
Levomilnacipran—Dyspnoea—Quinidine barbiturate—malaria	0.000354	0.00212	CcSEcCtD
Levomilnacipran—Dyspnoea—Pentoxifylline—malaria	0.000353	0.00212	CcSEcCtD
Levomilnacipran—Somnolence—Quinidine barbiturate—malaria	0.000353	0.00211	CcSEcCtD
Levomilnacipran—Somnolence—Pentoxifylline—malaria	0.000352	0.00211	CcSEcCtD
Levomilnacipran—Urticaria—Quinine—malaria	0.00035	0.00209	CcSEcCtD
Levomilnacipran—Urticaria—Quinidine—malaria	0.00035	0.00209	CcSEcCtD
Levomilnacipran—ABCB1—blood—malaria	0.000349	0.0104	CbGeAlD
Levomilnacipran—Dyspepsia—Pentoxifylline—malaria	0.000349	0.00209	CcSEcCtD
Levomilnacipran—Abdominal pain—Quinidine—malaria	0.000348	0.00208	CcSEcCtD
Levomilnacipran—Abdominal pain—Quinine—malaria	0.000348	0.00208	CcSEcCtD
Levomilnacipran—Body temperature increased—Quinine—malaria	0.000348	0.00208	CcSEcCtD
Levomilnacipran—Body temperature increased—Quinidine—malaria	0.000348	0.00208	CcSEcCtD
Levomilnacipran—Decreased appetite—Quinidine barbiturate—malaria	0.000345	0.00207	CcSEcCtD
Levomilnacipran—Decreased appetite—Pentoxifylline—malaria	0.000345	0.00206	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000343	0.00205	CcSEcCtD
Levomilnacipran—Constipation—Quinidine barbiturate—malaria	0.00034	0.00203	CcSEcCtD
Levomilnacipran—Constipation—Pentoxifylline—malaria	0.000339	0.00203	CcSEcCtD
Levomilnacipran—ABCB1—bone marrow—malaria	0.000338	0.01	CbGeAlD
Levomilnacipran—Hypersensitivity—Clindamycin—malaria	0.00033	0.00198	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000325	0.00195	CcSEcCtD
Levomilnacipran—Hypersensitivity—Quinine—malaria	0.000324	0.00194	CcSEcCtD
Levomilnacipran—Hypersensitivity—Quinidine—malaria	0.000324	0.00194	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Pentoxifylline—malaria	0.000324	0.00194	CcSEcCtD
Levomilnacipran—Asthenia—Clindamycin—malaria	0.000322	0.00193	CcSEcCtD
Levomilnacipran—Pruritus—Clindamycin—malaria	0.000317	0.0019	CcSEcCtD
Levomilnacipran—Asthenia—Quinine—malaria	0.000316	0.00189	CcSEcCtD
Levomilnacipran—Asthenia—Quinidine—malaria	0.000316	0.00189	CcSEcCtD
Levomilnacipran—Urticaria—Quinidine barbiturate—malaria	0.000315	0.00189	CcSEcCtD
Levomilnacipran—Urticaria—Pentoxifylline—malaria	0.000315	0.00189	CcSEcCtD
Levomilnacipran—Abdominal pain—Quinidine barbiturate—malaria	0.000314	0.00188	CcSEcCtD
Levomilnacipran—Body temperature increased—Quinidine barbiturate—malaria	0.000314	0.00188	CcSEcCtD
Levomilnacipran—Abdominal pain—Pentoxifylline—malaria	0.000313	0.00188	CcSEcCtD
Levomilnacipran—Body temperature increased—Pentoxifylline—malaria	0.000313	0.00188	CcSEcCtD
Levomilnacipran—Pruritus—Quinidine—malaria	0.000311	0.00186	CcSEcCtD
Levomilnacipran—Pruritus—Quinine—malaria	0.000311	0.00186	CcSEcCtD
Levomilnacipran—Diarrhoea—Clindamycin—malaria	0.000307	0.00184	CcSEcCtD
Levomilnacipran—CYP2D6—brain—malaria	0.000301	0.00895	CbGeAlD
Levomilnacipran—Diarrhoea—Quinidine—malaria	0.000301	0.0018	CcSEcCtD
Levomilnacipran—Diarrhoea—Quinine—malaria	0.000301	0.0018	CcSEcCtD
Levomilnacipran—Dizziness—Clindamycin—malaria	0.000297	0.00178	CcSEcCtD
Levomilnacipran—Vomiting—Dapsone—malaria	0.000295	0.00177	CcSEcCtD
Levomilnacipran—Hypersensitivity—Quinidine barbiturate—malaria	0.000293	0.00175	CcSEcCtD
Levomilnacipran—Hypersensitivity—Pentoxifylline—malaria	0.000292	0.00175	CcSEcCtD
Levomilnacipran—Dizziness—Quinidine—malaria	0.000291	0.00174	CcSEcCtD
Levomilnacipran—Dizziness—Quinine—malaria	0.000291	0.00174	CcSEcCtD
Levomilnacipran—Headache—Dapsone—malaria	0.00029	0.00174	CcSEcCtD
Levomilnacipran—Vomiting—Clindamycin—malaria	0.000285	0.00171	CcSEcCtD
Levomilnacipran—Asthenia—Quinidine barbiturate—malaria	0.000285	0.00171	CcSEcCtD
Levomilnacipran—Asthenia—Pentoxifylline—malaria	0.000284	0.0017	CcSEcCtD
Levomilnacipran—Rash—Clindamycin—malaria	0.000283	0.00169	CcSEcCtD
Levomilnacipran—Dermatitis—Clindamycin—malaria	0.000283	0.00169	CcSEcCtD
Levomilnacipran—Headache—Clindamycin—malaria	0.000281	0.00168	CcSEcCtD
Levomilnacipran—Pruritus—Quinidine barbiturate—malaria	0.000281	0.00168	CcSEcCtD
Levomilnacipran—Pruritus—Pentoxifylline—malaria	0.00028	0.00168	CcSEcCtD
Levomilnacipran—Vomiting—Quinine—malaria	0.00028	0.00168	CcSEcCtD
Levomilnacipran—Vomiting—Quinidine—malaria	0.00028	0.00168	CcSEcCtD
Levomilnacipran—Rash—Quinidine—malaria	0.000277	0.00166	CcSEcCtD
Levomilnacipran—Rash—Quinine—malaria	0.000277	0.00166	CcSEcCtD
Levomilnacipran—Dermatitis—Quinine—malaria	0.000277	0.00166	CcSEcCtD
Levomilnacipran—Dermatitis—Quinidine—malaria	0.000277	0.00166	CcSEcCtD
Levomilnacipran—Headache—Quinidine—malaria	0.000276	0.00165	CcSEcCtD
Levomilnacipran—Headache—Quinine—malaria	0.000276	0.00165	CcSEcCtD
Levomilnacipran—Nausea—Dapsone—malaria	0.000275	0.00165	CcSEcCtD
Levomilnacipran—ABCB1—liver—malaria	0.000273	0.00811	CbGeAlD
Levomilnacipran—Diarrhoea—Quinidine barbiturate—malaria	0.000272	0.00163	CcSEcCtD
Levomilnacipran—Diarrhoea—Pentoxifylline—malaria	0.000271	0.00162	CcSEcCtD
Levomilnacipran—Nausea—Clindamycin—malaria	0.000266	0.0016	CcSEcCtD
Levomilnacipran—Dizziness—Quinidine barbiturate—malaria	0.000263	0.00157	CcSEcCtD
Levomilnacipran—Dizziness—Pentoxifylline—malaria	0.000262	0.00157	CcSEcCtD
Levomilnacipran—Nausea—Quinine—malaria	0.000261	0.00157	CcSEcCtD
Levomilnacipran—Nausea—Quinidine—malaria	0.000261	0.00157	CcSEcCtD
Levomilnacipran—Vomiting—Quinidine barbiturate—malaria	0.000252	0.00151	CcSEcCtD
Levomilnacipran—Vomiting—Pentoxifylline—malaria	0.000252	0.00151	CcSEcCtD
Levomilnacipran—Rash—Quinidine barbiturate—malaria	0.00025	0.0015	CcSEcCtD
Levomilnacipran—Dermatitis—Quinidine barbiturate—malaria	0.00025	0.0015	CcSEcCtD
Levomilnacipran—Rash—Pentoxifylline—malaria	0.00025	0.0015	CcSEcCtD
Levomilnacipran—Dermatitis—Pentoxifylline—malaria	0.00025	0.0015	CcSEcCtD
Levomilnacipran—Headache—Quinidine barbiturate—malaria	0.000249	0.00149	CcSEcCtD
Levomilnacipran—Headache—Pentoxifylline—malaria	0.000248	0.00149	CcSEcCtD
Levomilnacipran—Nausea—Quinidine barbiturate—malaria	0.000236	0.00141	CcSEcCtD
Levomilnacipran—Nausea—Pentoxifylline—malaria	0.000235	0.00141	CcSEcCtD
Levomilnacipran—ABCB1—brain—malaria	0.000217	0.00644	CbGeAlD
